Lithium Carbonate Tablet, Extended Release
Product Images NDC 64980-278

2 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 64980-278). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Lithium Carbonate 450mg-100ct (Lithium Carbonate 450mg 100ct)

Lithium Carbonate 450mg-100ct (Lithium Carbonate 450mg 100ct)
Packaging label for Lithium Carbonate Extended-Release Tablets USP, 450 mg strength, containing 100 tablets. The label shows the brand Rising Pharmaceuticals and the NDC 64980-278-01. It lists the manufacturer as Unique Pharmaceutical Laboratories in Mumbai, India, and the distributor as Rising Pharma Holdings, Inc. in East Brunswick, NJ. The label includes dosing, storage, warnings, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.